Literature DB >> 10779760

IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck.

M C Bosco1, R E Curiel, A H Zea, M G Malabarba, J R Ortaldo, I Espinoza-Delgado.   

Abstract

The activating properties of IL-2 and the structure of the IL-2R on human monocytes are well characterized. However, relatively little is known about the biochemical mechanisms involved in IL-2 signal transduction in these cells. We investigated the role of protein tyrosine kinases (PTKs) in the activation of monocytes by IL-2. Incubation of monocytes with the PTK inhibitor herbimycin A (HA) resulted in the dose-dependent suppression of IL-2-induced monocyte tumoricidal activity. This inhibition was rather potent, as a concentration of HA as low as 0.5 microM caused a complete abrogation of cytolytic activity. Furthermore, HA markedly suppressed the ability of IL-2 to induce IL-1 beta, TNF-alpha, IL-6, and IL-8 mRNA expression and protein secretion by monocytes. Anti-phosphotyrosine immunoblotting demonstrated that IL-2 induced a rapid and time-dependent increase in tyrosine phosphorylation of several cellular proteins of molecular masses ranging from 35 to 180 kDa. Interestingly, IL-2 caused a significant up-regulation of the constitutive levels of hck PTK mRNA and protein relative to medium-treated cells as well as an increase in p59hck tyrosine phosphorylation. Finally, we demonstrated by in vitro kinase assay that the specific activity of p59hck PTK was also induced by IL-2 in monocytes. Thus, these data show that the activation of PTKs is required for the triggering of monocyte effector and secretory functions by IL-2 and strongly suggest that p59hck is a key participant in IL-2 signaling in human monocytes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779760     DOI: 10.4049/jimmunol.164.9.4575

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Hck is a key regulator of gene expression in alternatively activated human monocytes.

Authors:  Ashish Bhattacharjee; Srabani Pal; Gerald M Feldman; Martha K Cathcart
Journal:  J Biol Chem       Date:  2011-08-30       Impact factor: 5.157

2.  Src family kinases are required for prolactin induction of cell proliferation.

Authors:  J A Fresno Vara ; M A Cáceres; A Silva; J Martín-Pérez
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

3.  Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming.

Authors:  Giorgia De Simone; Francesco Andreata; Camille Bleriot; Valeria Fumagalli; Chiara Laura; José M Garcia-Manteiga; Pietro Di Lucia; Stefano Gilotto; Xenia Ficht; Federico F De Ponti; Elisa B Bono; Leonardo Giustini; Gioia Ambrosi; Marta Mainetti; Paola Zordan; Alexandre P Bénéchet; Micol Ravà; Svetoslav Chakarov; Federica Moalli; Marc Bajenoff; Luca G Guidotti; Florent Ginhoux; Matteo Iannacone
Journal:  Immunity       Date:  2021-08-31       Impact factor: 43.474

4.  Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.

Authors:  G M Bahr; E C A Darcissac; Y Mouton
Journal:  Clin Exp Immunol       Date:  2003-05       Impact factor: 4.330

Review 5.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

6.  Effects of interleukin-2 in immunostimulation and immunosuppression.

Authors:  Jonathan G Pol; Pamela Caudana; Juliette Paillet; Eliane Piaggio; Guido Kroemer
Journal:  J Exp Med       Date:  2020-01-06       Impact factor: 14.307

7.  Regulation of p73 by Hck through kinase-dependent and independent mechanisms.

Authors:  Preeti Paliwal; Vegesna Radha; Ghanshyam Swarup
Journal:  BMC Mol Biol       Date:  2007-05-30       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.